van Lümig, P P M <br/><br/>
Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab.  [electronic resource] 

 -  The British journal of dermatology  Aug 2011 
 - 375-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2133.2011.10329.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Antibodies, Antinuclear--metabolism<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>C-Reactive Protein--metabolism<br/>Clinical Laboratory Techniques--statistics & numerical data<br/>Drug Monitoring--methods<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor